GlassScriptPhysician profile
Adam Young
NPI 1073769287
$29,140.35
in general payments reported to CMS, 2019-2025
26 companies · $3,045 in 2025
The $3,045 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $5,101 · 2021: $1,361 · 2022: $1,039 · 2023: $15K · 2024: $2,956 · 2025: $3,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $8,001 · Travel and Lodging: $1,070 · Education: $33.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,500.00 |
| Food and Beverage | $8,000.58 |
| Travel and Lodging | $1,070.41 |
| Education | $33.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $12,006.46 | 2021-2024 | Mild Device Kit |
| Abbott Laboratories | $5,229.00 | 2019-2025 | Eterna, Proclaim, Octrode |
| Baxter Healthcare | $4,000.00 | 2020 | |
| Boston Scientific Corporation | $1,623.22 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Saluda Medical Americas, INC. | $1,334.14 | 2023-2024 | Evoke Scs, Evoke |
| Painteq LLC | $598.01 | 2021-2025 | Painteq |
| Nevro Corp. | $571.33 | 2020-2023 | Senza |
| Biotronik Nro, INC. | $509.62 | 2024-2025 | Prospera |
| Medtronic USA, INC. | $428.08 | 2019-2020 | |
| Nalu Medical, INC. | $328.60 | 2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $324.09 | 2021-2025 | Cd Horizon Spinal System |
| Lenoss Medical INC | $310.45 | 2025 | Osteopearl |
| Spinal Simplicity, LLC | $300.70 | 2025 | Ha Minuteman G3-R, Patriot Si |
| Averitas Pharma INC. | $259.13 | 2023-2024 | Qutenza |
| Spr Therapeutics, INC | $240.51 | 2019-2025 | Sprint Pns System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $184.42 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $160.35 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $136.19 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $129.41 | 2022-2024 | Iovera |
| Novo Nordisk INC | $116.06 | 2022 | |
| Integra Lifesciences Corporation | $91.41 | 2022 | |
| Vertiflex, INC. | $88.82 | 2019 | |
| Relievant Medsystems, INC. | $71.03 | 2022-2023 | Intracept |
| Bard Access Systems, INC. | $44.37 | 2019 | |
| Si-Bone, INC. | $30.94 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $24.01 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.